Chromosome instability and oxidative stress markers in patients with ataxia telangiectasia and their parents. 2013

Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.

Ataxia telangiectasia (AT) is a rare neurodegenerative disorder, inherited in an autosomal recessive manner. Total blood samples were collected from 20 patients with AT, 13 parents of patients, and 17 healthy volunteers. This study aimed at evaluating the frequency of chromosomal breaks in spontaneous cultures, induced by bleomycin and ionizing radiation, and further evaluated the rates of oxidative stress in AT patients and in their parents, compared to a control group. Three cell cultures were performed to each individual: the first culture did not receive induction to chromosomal instability, the second was exposed to bleomycin, and the last culture was exposed to ionizing radiation. To evaluate the rates of oxidative stress, the markers superoxide dismutase (SOD), catalase (CAT), and thiobarbituric acid (TBARS) were utilized. Significant differences were observed between the three kinds of culture treatments (spontaneous, bleomycin, and radiation induced) and the breaks and chromosomal aberrations in the different groups. The oxidative stress showed no significant differences between the markers. This study showed that techniques of chromosomal instability after the induction of ionizing radiation and bleomycin are efficient in the identification of syndrome patients, with the ionizing radiation being the most effective.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011839 Radiation, Ionizing ELECTROMAGNETIC RADIATION or particle radiation (high energy ELEMENTARY PARTICLES) capable of directly or indirectly producing IONS in its passage through matter. The wavelengths of ionizing electromagnetic radiation are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays. Ionizing Radiation,Ionizing Radiations,Radiations, Ionizing
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
June 2002, Antioxidants & redox signaling,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
January 2003, Redox report : communications in free radical research,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
April 2024, Pediatric neurology,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
September 1999, Clinical and experimental immunology,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
December 2018, Mutation research. Genetic toxicology and environmental mutagenesis,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
January 2022, Genome integrity,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
August 1982, Cancer genetics and cytogenetics,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
October 1990, Cancer letters,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
September 1980, The Journal of pediatrics,
Luciane Bitelo Ludwig, and Victor Hugo Valiati, and Roberta Passos Palazzo, and Laura Bannach Jardim, and Darlan Pase da Rosa, and Silvia Bona, and Graziela Rodrigues, and Norma Possa Marroni, and Daniel Prá, and Sharbel Weidner Maluf
March 1970, Lancet (London, England),
Copied contents to your clipboard!